Thermo Fisher beefs up its animal health Dx offerings with a Swiss acquisition

A little over a month after Thermo Fisher Scientific ($TMO) closed its gigantic $13.6 billion buyout of Life Technologies, it has sealed a much more targeted deal. The Waltham, MA, laboratory equipment giant said it has completed the acquisition of Prionics AG, a privately held Swiss animal health diagnostics company. Neither side is disclosing financial details. But the agreement gives Thermo Fisher access to more than 50 diagnostic test kits, plus accessories and biochemicals that will help expand similar offerings under the Life Technologies brand. Prionics, which first launched in 1997, maintains a major manufacturing facility in the Netherlands, according to the deal announcement. Item

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.